Literature DB >> 10934075

Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1.

N P Juffermans1, A Verbon, J T Belisle, P J Hill, P Speelman, S J van Deventer, T van der Poll.   

Abstract

Lipoarabinomannan (LAM), a cell wall component of Mycobacterium tuberculosis, induces the production of cytokines and chemokines in vitro. Interleukin-1 (IL-1) contributes to granuloma formation in tuberculosis (TB), and exerts effects via the IL-1 receptor type I (IL-1R). To determine the effects of LAM in the pulmonary compartment in vivo and to establish the role of endogenous IL-1 herein, normal and IL-1R deficient ((-/-)) mice were intranasally inoculated with LAM (50 microgram). In normal mice, LAM resulted in a neutrophilic cell influx into the bronchoalveolar lavage fluid (BALF). LAM also induced increases in the lung concentrations of macrophage inflammatory protein-2 (MIP-2), keratinocyte (KC), tumor necrosis factor-alpha (TNF-alpha), IL-1alpha, and IL-1beta. IL-1R(-/-) mice had less influx of granulocytes in their BALF than wild-type mice. Also, lung TNF-alpha levels were lower in IL-1R(-/-) mice. LAM may be an important stimulator of innate immunity in infection with M. tuberculosis via mechanisms that involve endogenous IL-1 activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934075     DOI: 10.1164/ajrccm.162.2.9911009

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.

Authors:  Prithwiraj De; Libin Shi; Claudia Boot; Diane Ordway; Michael McNeil; Delphi Chatterjee
Journal:  ACS Infect Dis       Date:  2019-12-12       Impact factor: 5.084

2.  Multianalyte Microphysiometry of Macrophage Responses to Phorbol Myristate Acetate, Lipopolysaccharide, and Lipoarabinomannan.

Authors:  Danielle W Kimmel; Mika E Meschievitz; Leslie A Hiatt; David E Cliffel
Journal:  Electroanalysis       Date:  2013-07-01       Impact factor: 3.223

3.  Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria.

Authors:  Shannon K Roach; Jeffrey S Schorey
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Gregory Foster; David N McMurray
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice.

Authors:  Jaklien C Leemans; Mirjam Heikens; Kok P M van Kessel; Sandrine Florquin; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

6.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

7.  Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells.

Authors:  Jillian M Richmond; Jinhee Lee; Daniel S Green; Hardy Kornfeld; William W Cruikshank
Journal:  J Immunol       Date:  2012-11-05       Impact factor: 5.422

8.  The Caenorhabditis elegans p38 MAPK Gene plays a key role in protection from mycobacteria.

Authors:  Thushara Galbadage; Tonya F Shepherd; Suat L G Cirillo; Tina L Gumienny; Jeffrey D Cirillo
Journal:  Microbiologyopen       Date:  2016-02-25       Impact factor: 3.139

Review 9.  Mycobacterium and the coat of many lipids.

Authors:  David G Russell; Henry C Mwandumba; Elizabeth E Rhoades
Journal:  J Cell Biol       Date:  2002-07-29       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.